Smart Syringe Market, By Product (Auto Disable Syringes, Active Safety Syringes, Passive Safety Syringes), By Age Group (Pediatrics and Adults), By Application (Drug Delivery, Vaccination, Blood Specimen Collection), By End User (Hospitals & HMOs, Diabetic Patients, Family Practices, Psychiatrics and Others), By Region (North America, Europe, Asia Pacific, Middle East & Africa and South America) – Market Size & Forecasting to 2028

This research report categorizes the market for smart syringes based on various segments and regions and forecasts revenue growth and analysis of trends in each of the submarkets. The report analyses the key growth drivers, opportunities and challenges, which influence the smart syringe market. Recent market developments and competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included in order to draw the competitive landscape in the smart syringe market. The report strategically identifies and profiles the key market players and analyses their core competencies in each type and application of the smart syringe market.

FIGURE 1 smart syringe Market – Market Scope

The Smart Syringe Market was valued at USD XX million in 2020 and it is estimated to reach USD XX million by 2028 at a CAGR of XX% during the forecast period. The factors such as the increase in the count of needle stick injuries; high prevalence of blood-borne transmission such as hepatitis B, C, and HIV through improper injection practices; growth in adoption of safety syringes; and advancements in technology drive the market growth.

Smart syringes can be defined as medical devices that are engineered with safety mechanisms to prevent the reuse of syringes and regulate unsafe injection practices. They are equipped with features to avoid needlestick injuries in a person who uses these syringes and prevent transmission of blood-borne diseases such as hepatitis C virus (HCV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). However, mandatory recommendations by the WHO to switch to smart syringes, ensuring safe injection practices is the major factor that boosts the market growth.

The smart Syringe market is segmented based on product, application, age group, end-use, and region

FIGURE 2 smart syringe MARKET: by-product, 2020 -2028

Based on the product, the smart syringe market is segmented into auto disable syringes, active safety syringes, and passive safety syringes. Among these, the passive safety syringes segment is expected to emerge as the fastest-growing segment during the forecast period. The relatively fast growth of this segment is attributed to their ease of use, increased patient safety due to the automatic activation of the safety feature, and the prevention of infection transmission achieved with these syringes.

FIGURE 3 smart syringe MARKET: by Age Group, 2020 – 2028

Based on age group, the smart syringe market is segmented into pediatrics and adults. Pediatrics is the most lucrative segment due to the increase in a number of pediatric populations, aged between 0 and 18 years, every year, as this age group is more vulnerable to transmitted infections.

FIGURE 4 smart syringe MARKET: by End User, 2020 – 2028

By end-user, it is classified into hospitals & HMOs (Health Maintenance Organizations), diabetic patients, family practices, psychiatric, and others. Hospitals & HMOs are the leading users of smart syringes for drug delivery, vaccination, and collecting blood samples. The Mayo Clinic, Johns Hopkins Hospital, UCLA Medical Center, and Cleveland Clinic are some hospitals that use smart syringes. Although these hospitals were late in adopting these syringes, they have recently increased and mandated the use of smart syringes after the WHO recommendations for the prevention of needlestick injuries.

FIGURE 5 smart syringe MARKET: by application, 2020 – 2028

Based on application, the smart syringe market is segmented into drug delivery, vaccination, and blood specimen collection. Among these, the drug delivery segment accounted for the maximum market share during the forecast period. An increase in the prevalence of target diseases and the existent, high unmet needs of vaccination across the emerging economies are expected to accelerate the market growth over the forecast period.

FIGURE 6 smart syringe market: by region, 2017-2028

By region, the market has been divided into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America accounted for the largest share during the forecast period. The high share is attributed to the increasing awareness about needle stick injuries, the continual improvements in healthcare practices, the presence of a huge geriatric population base, and the existence of well-developed primary and secondary healthcare centers across the region. Another side, Asia Pacific is expected to emerge as the fastest-growing region during the forecast period. Increases in the public and private healthcare expenditure levels to support efforts in curbing disease transmission and improve patient care are amongst the key reasons favoring the market growth over the forecast period. In addition, China was expected to have the largest number of electric vehicles in use in 2018 and to continue to manufacture the most electric vehicles in the Asia Pacific region in 2022. Together with Japan and South Korea, these three Asian countries lead in the field of electromobility worldwide Although South Korea is technologically advanced, Japan and China have a major production and market share advantage.

The competitive scenario highlights the performance of major companies operating in this market. This includes the detailed profiling of major companies and their competitive benchmarking. Product profiling provides key information including products/solutions offered, key developments, company performances, and strategies adopted in recent years. Major companies profiled in the market Becton, Dickinson, and Co. Braun Melsungen AG, Terumo Medical Corporation, Baxter International, Inc., Retractable Technologies, Inc., Smiths Group Plc,  and Revolutions Medical Corporation. These companies have adopted product development, expansion, and merger strategies to consolidate market position amongst the intense competition.

Market Segmentation:

By Product Type 
    • Auto Disable
    • Active Safety
    • Passive Safety

By Application 
    • Drug Delivery
    • Vaccination
    • Blood Specimen Collection 

By Age Group 
    • Pediatric
    • Adult

By End User 
    • Hospitals & HMOs
    • Diabetic Patients 
    • Family Practices 
    • Psychiatrics

By Region:

    •     North America
        ◦  North America, by Country
            ▪ US
            ▪ Canada
            ▪ Mexico
        ◦ North America, by Product Type
        ◦ North America, by End-User
        ◦ North America, by Application
        ◦ North America, by Age Group

    •     Western Europe
        ◦ Western Europe, by Country
            ▪ Germany
            ▪ UK
            ▪ France
            ▪ Italy
            ▪ Spain
            ▪ The Netherlands
            ▪ Rest of Western Europe
        ◦ Western Europe, by Product Type
        ◦ Western Europe, by End-User
        ◦ Western Europe, by Application
        ◦ Western Europe, by Age Group

    •     Asia Pacific
        ◦ Asia Pacific, by Country
            ▪ China
            ▪ India
            ▪ Japan
            ▪ South Korea
            ▪ Australia
            ▪ Indonesia
            ▪ Rest of Asia Pacific
        ◦ Asia Pacific, by Product Type
        ◦ Asia Pacific, by End-User
        ◦ Asia Pacific, by Application
        ◦ Asia Pacific, by Age Group

    •     Eastern Europe
        ◦ Eastern Europe, by Country
            ▪ Russia
            ▪ Turkey
            ▪ Rest of Eastern Europe
        ◦ Eastern Europe, by Product Type
        ◦ Eastern Europe, by End-User
        ◦ Eastern Europe, by Application
        ◦ Eastern Europe, by Age Group

    •     Middle East
        ◦ Middle East, by Country
            ▪ UAE
            ▪ Saudi Arabia
            ▪ Qatar
            ▪ Iran
            ▪ Rest of Middle East
        ◦ Middle East, by Product Type
        ◦ Middle East, by End-User
        ◦ Middle East, by Application
        ◦ Middle East, by Age Group

    •     Rest of the World
        ◦ Rest of the World, by Country
            ▪ South America
            ▪ Africa
        ◦ Rest of the World, by Product Type
        ◦ Rest of the World, by End-User
        ◦ Rest of the World, by Application
        ◦ Rest of the World, by Age Group

Years Covered in the Study:
Historic Year: 2016-2017
Base Year:2018
Estimated Year: 2019
Forecast Year: 2028

Objectives of this report:
• To estimate the market size for the smart syringe market on a regional and global basis.
• To identify major segments in the smart syringe market and evaluate their market shares and demand.
• To provide a competitive scenario for the smart syringe market with major developments observed by key companies in the historic years.
• To evaluate key factors governing the dynamics of smart syringe market with their potential gravity during the
forecast period.

Reasons to Buy This Report:

    • Provides niche insights for decisions about every possible segment helping in the strategic decision-making process.
    • Market size estimation of the smart syringe market on a regional and global basis.
    • A unique research design for market size estimation and forecast.
    • Identification of major companies operating in the market with related developments
    • Exhaustive scope to cover all the possible segments helping every stakeholder in the smart syringe market.

Customization:

This study is customized to meet your specific requirements:

    • By Segment
    • By Sub-segment
    • By Region/Country
    • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com